Keywords: کارآیی واکسن; Herpes zoster; Varicella-zoster virus; Vaccine efficacy; Complications; Postherpetic neuralgia; Hospitalisation;
مقالات ISI کارآیی واکسن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارآیی واکسن; VZV; varicella-zoster virus; MMR; measles-mumps-rubella; MMRV; measles-mumps-rubella-varicella; CI; confidence interval; SAE; serious adverse event; HZ; herpes zoster; VE; vaccine efficacy; ATP; according-to-protocol; CDC; Centers for Disease Control and
Keywords: کارآیی واکسن; Foot-and-mouth disease virus; Vaccine efficacy; Heterologous challenge; Sheep;
Keywords: کارآیی واکسن; Bovine viral diarrhea virus; Cattle; Vaccine efficacy; Inactivated vaccine; Reproductive protection; Fetal protection; kV; killed viral; MLV; modified live viral; FI; fetal infection; BVDV; Bovine viral diarrhea virus;
Keywords: کارآیی واکسن; Bovine viral diarrhea virus; Bovine herpesvirus 1; Cattle; Vaccine efficacy; Reproductive protection;
Keywords: کارآیی واکسن; Community-acquired pneumonia; Invasive pneumococcal disease; Pneumococcal conjugate vaccine; Streptococcus pneumoniae; ABC; Active Bacterial Core surveillance; ACIP; Advisory Committee on Immunization Practices; BAC; bacteremic; CAP; community acquired pn
Keywords: کارآیی واکسن; Streptococcus pneumoniae; Nasopharyngeal carriage; Pneumolysin; Pneumococcal histidine triad protein D; Vaccine efficacy; Infant; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; dPly; pneumolysin toxoid; ELISA; enzyme-linked immuno
Keywords: کارآیی واکسن; Capripoxvirus; Kenyan sheep pox (KS1 O-180) vaccine; Lumpy skin disease; Reproduction ratio; Severity; Vaccine efficacy;
Keywords: کارآیی واکسن; Vc; critical vaccination coverage; Ic; herd immunity threshold; R0; basic reproductive number; E; vaccine efficacy; Ebola; Vaccine; Herd immunity; Ring vaccination;
Keywords: کارآیی واکسن; Influenza vaccine; Vaccine efficacy; Respiratory infection; Influenza-like illness;
Keywords: کارآیی واکسن; Pig; Mycotoxins; Feed contamination; Susceptibility to disease; Immunity; Vaccine efficacy
Keywords: کارآیی واکسن; Test negative design; Case-control; Vaccine trial; Cholera; Vaccine efficacy;
Keywords: کارآیی واکسن; Influenza vaccine; Elderly; Vaccine efficacy; Immunosenescence; Repeated vaccination;
Keywords: کارآیی واکسن; Vaccinia virus; Immunogenicity; NF-κB inhibitor; IRF3 inhibitor; Vaccine efficacy;
Keywords: کارآیی واکسن; Malignant catarrhal fever; Alcelaphine herpesvirus 1; Wildebeest; Vaccine field trial; Vaccine efficacy; Tanzania;
Keywords: کارآیی واکسن; OPV; oral polio vaccine; RV; rotavirus vaccine; NPEV; non-polio enterovirus; EV; enterovirus; PROVIDE; Performance of Rotavirus and Oral Polio Vaccines in Developing Countries; IPV; inactivated poliovirus vaccine; EAEC; enteroaggregative E. coli; EIEC; en
Keywords: کارآیی واکسن; HA; hemagglutinin; NA; neuraminidase; HI; hemagglutination inhibition; HAU; hemagglutination unit; MN; microneutralization; LD50; 50% lethal dose; PFU; plaque forming unit; Influenza virus; Infection; Antigenic drift; Vaccine efficacy; Pandemic H1N1;
Keywords: کارآیی واکسن; Vaccine efficacy; Vaccine preventable disease incidence; Vaccine effectiveness; Vaccine probe analysis; Beyond vaccine efficacy; Conference report;
Keywords: کارآیی واکسن; IS; immunosuppressive; AD; autoimmune disease; HIV; human immunodeficiency virus; PCP; pneumocystis pneumonia; VE; vaccine efficacy; ANCA; antineutrophil cytoplasmatic antibodies; SLE; systemic lupus erythematosus; ASIA; autoimmune inflammatory syndrome i
Keywords: کارآیی واکسن; Animal rule; Vaccine efficacy; Bootstrap; Confidence interval; Simulation;
Keywords: کارآیی واکسن; IIV-HD; high-dose inactivated influenza vaccine; HA; hemagglutinin; IIV-SD; standard-dose inactivated intramuscular influenza vaccine; CI; confidence interval; HAI; hemagglutination inhibition; PD-ILI; protocol-defined influenza-like illness; NP; nasophar
Keywords: کارآیی واکسن; HIV, human immunodeficiency virus; NHP, non-human primates; SF, San Francisco; SA, South Africa; VE, vaccine efficacy; ART, antiretroviral therapyHIV epidemic; Mathematical modeling; Vaccine efficacy; HIV prevention; Intervention effectiveness
Keywords: کارآیی واکسن; NDV; Vaccine efficacy; Newcastle disease; Homologous vaccination; Mortality;
Keywords: کارآیی واکسن; Nanovaccines; Animal models; Translation; Vaccine efficacy;
Keywords: کارآیی واکسن; Cholera; Epidemiology; Haemophilus influenzae type b; Hib; Immunization; Malaria; Rotavirus; RTS,S; Pneumococcus; Streptococcus pneumoniae; Vaccine; Vaccine efficacy; Vaccine effectiveness;
Keywords: کارآیی واکسن; CMI; cellular mediated immunity; CoP; correlate of protection; ELISA; enzyme-linked immunosorbent assay; HA; haemagglutinin; HI; haemagglutination inhibition assay; HPAIV; highly pathogenic avian influenza viruses; HPLC; high-performance liquid chromatogr
Keywords: کارآیی واکسن; CC; cervical cancer; CIN; cervical intraepithelial neoplasia; HPV; human papillomavirus; TVC; total vaccinated cohort; HSIL; high-grade squamous intraepithelial lesion; ICO; Institut Català d'Oncologia; VE; vaccine efficacy; WHO; World Health Organizat
Keywords: کارآیی واکسن; Marek's disease; Host genetics; Vaccine efficacy;
Keywords: کارآیی واکسن; Vaccine efficacy; Bacterial pathogens; Randomised controlled trials; Methodological research; Mathematical modelling
Keywords: کارآیی واکسن; PCV; pneumococcal conjugate vaccine; VEcol; vaccine efficacy against colonisation; VEacq; vaccine efficacy against acquisition of colonisation; VET; combined vaccine efficacy against acquisition and duration of colonisation; VT; vaccine (sero)type(s); NVT
Keywords: کارآیی واکسن; OR; odds ratio; PCV; pneumococcal conjugate vaccine; VEcol; vaccine efficacy against colonisation; VEacq; vaccine efficacy against acquisition of colonisation; VET; combined vaccine efficacy against acquisition and duration of colonisation; VT; vaccine (s
Keywords: کارآیی واکسن; Influenza; Vaccine; Pandemic; Vaccine efficacy;
Keywords: کارآیی واکسن; Porcine circovirus type 2; Escherichia coli expression; Virus-like particle; Cryo-EM structure; Vaccine efficacy
A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species
Keywords: کارآیی واکسن; Foot-and-mouth disease; Pigs; Vaccine efficacy; Challenge; Serotype SAT;
Meta-analysis of the efficacy of Leptospira serovar Hardjo vaccines to prevent urinary shedding in cattle
Keywords: کارآیی واکسن; Leptospira; Hardjo; Vaccine efficacy; Urinary; Shedding; Meta-analysis; Bayesian analysis;
Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine
Keywords: کارآیی واکسن; AdtA24; replication-deficient human adenovirus vectored FMDV A24/Cruzeiro/BRA/55 vaccine; APHIS; Animal and Plant Health Inspection Services; CVB; Center for Veterinary Biologics; DIVA; differentiate infected from vaccinated animals; dpc; days post-challe
Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States
Keywords: کارآیی واکسن; Vaccine; Vaccination; Herpes zoster; Public health impact; Cost-effectiveness; ACIP; Advisory Committee on Immunization Practices; AEs; adverse events; DSA; deterministic sensitivity analysis; HZ; shingles, Herpes zoster; RZV; Adjuvanted Recombinant Zoste
Hybrid baculovirus-mediated prolonged hemagglutinin expression and secretion in vivo enhances the vaccine efficacy
Keywords: کارآیی واکسن; Influenza vaccine; Baculovirus; DNA minicircle; Prolonged expression; Hemagglutinin secretion; Vaccine efficacy;
Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine
Keywords: کارآیی واکسن; Human papillomavirus; HPV; Non-inferiority trial; Vaccine efficacy; Clinical trial;
Dengue vaccine safety signal: Immune enhancement, waning immunity, or chance occurrence?
Keywords: کارآیی واکسن; ADE; antibody dependent enhancement; CI; confidence interval; CYD14; Asian phase 3 clinical trial; CYD15; Latin America phase 3 clinical trial; CYD23/57; Thailand phase 2b clinical trial; VCD; virologically-confirmed dengue; VE; vaccine efficacy; Adverse
Post-hoc analysis of a randomized controlled trial: Diabetes mellitus modifies the efficacy of the 13-valent pneumococcal conjugate vaccine in elderly
Keywords: کارآیی واکسن; Pneumococcal conjugate vaccine; Comorbidities; Elderly; Vaccine efficacy; Effect modification;
A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions
Keywords: کارآیی واکسن; Porcine circovirus; PCV2; PCV2d; Vaccination; Vaccine efficacy; Transmission;
Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination
Keywords: کارآیی واکسن; Foot-and-mouth disease virus; Vaccine efficacy; Heterologous challenge; Cattle;
Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Keywords: کارآیی واکسن; Community-acquired pneumonia; Invasive pneumococcal disease; PCV13; Pneumococcal conjugate vaccine; Vaccine efficacy; Adult;
Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M⢠adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes
Keywords: کارآیی واکسن; NIV; nanoparticle influenza vaccine; HANP; hemagglutinin nanoparticle; IIV; inactivated influenza vaccine; IIV-HD; inactivated influenza vaccine high dose; VE; vaccine efficacy; Ctrl; control; Recombinant; Hemagglutinin; Nanoparticles; Influenza; Vaccine;
Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep
Keywords: کارآیی واکسن; Foot and mouth disease virus; Vaccine efficacy; Dose response; Heterologous challenge; Sheep;
Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015Â U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus
Keywords: کارآیی واکسن; APHIS; the animal and plant health inspection service; ABSL3; animal biosafety level 3; BSL3Ag; biosafety level 3 for agriculture group housed animals; BPL; beta-propiolactone; BSL3E; biosafety level 3 elevated; DIVA; differentiate infected from vaccinate
Commercial vaccines provide limited protection to NADC30-like PRRSV infection
Keywords: کارآیی واکسن; NADC30-like PRRSV; Commercial PRRSV vaccines; Vaccine efficacy;
Influence of four commercial porcine circovirus type 2 (PCV2) vaccines on the improvement of production parameters in pigs with maternally derived antibodies
Keywords: کارآیی واکسن; Vaccine efficacy; Porcine circovirus type 2; Sow; Piglet; Maternally derived antibodies; Production parameters
Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies
Keywords: کارآیی واکسن; Avian influenza; Influenza; Vaccine efficacy; Vaccines; Pandemic influenza;